Reciprocal regulation of rac1 and PAK-1 by HIF-1α: A positive-feedback loop promoting pulmonary vascular remodeling

Antioxidants and Redox Signaling

Volumn 13, Issue 4, 2010, Pages 399-412

  Diebold, Isabel ^a   Petry, Andreas ^a   Djordjevic, Talija ^a   Belaiba, Rachida S ^a   Fineman, Jeffrey ^b   Black, Stephen ^c   Schreiber, Christian ^a   Fratz, Sohrab ^a   Hess, John ^a   Kietzmann, Thomas ^d,e   Görlach, Agnes ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; P21 ACTIVATED KINASE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUNG BLOOD VESSEL; LUNG PARENCHYMA; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PULMONARY ARTERY; PULMONARY VASCULAR DISEASE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CALCIUM; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ENZYME ACTIVATION; FEMALE; HEP G2 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; P21-ACTIVATED KINASES; PREGNANCY; PULMONARY ARTERY; RAC1 GTP-BINDING PROTEIN; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHEEP; THROMBIN;

OVIS ARIES;

EID: 77953505608     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.3013     Document Type: Article

References (48)

1. BelAiba RS, Djordjevic T, Bonello S, Artunc F, Lang F, Hess J, and Gorlach A. The serum-and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by throm-bin. Circ Res 98: 828-836, 2006.
2. Bokoch GM. Biology of the p21-activated kinases. Annu Rev Biochem 72: 743-781, 2003.
3. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, and Gorlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol 27: 755-761, 2007.
4. Brandes RP, Miller FJ, Beer S, Haendeler J, Hoffmann J, Ha T, Holland SM, Gorlach A, and Busse R. The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. Free Radic Biol Med 32: 1116-1122, 2002.
5. DeMarco VG, Habibi J, Whaley-Connell AT, Schneider RI, Heller RL, Bosanquet JP, Hayden MR, Delcour K, Cooper SA, Andresen BT, Sowers JR, and Dellsperger KC. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat. Am J Physiol Heart Circ Physiol 294: H2659-H2668, 2008.
6. Dery MA, Michaud MD, and Richard DE. Hypoxia-induc-ible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37: 535-540, 2005.
7. Diebold I, Djordjevic T, Hess J, and Gorlach A. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription. Thromb Haemost 100: 1021-1028, 2008.
8. Dimova EY and Kietzmann T. Cell type-dependent regulation of the hypoxia-responsive plasminogen activator inhibitor-1 gene by upstream stimulatory factor-2. J Biol Chem 281: 2999-3005, 2006.
9. Djordjevic T, BelAiba RS, Bonello S, Pfeilschifter J, Hess J, and Gorlach A. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 25: 519-525, 2005.
10. Djordjevic T, Hess J, Herkert O, Gorlach A, and BelAiba RS. Rac regulates thrombin-induced tissue factor expression in pulmonary artery smooth muscle cells involving the nuclear factor-kappaB pathway. Antioxid Redox Signal 6: 713-720, 2004.
11. Djordjevic T, Pogrebniak A, BelAiba RS, Bonello S, Wotzlaw C, Acker H, Hess J, and Gorlach A. The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radic Biol Med 38: 616-630, 2005.
12. Dummler B, Ohshiro K, Kumar R, and Field J. Pak protein kinases and their role in cancer. Cancer Metastasis Rev 28: 51-63, 2009.
13. Fay WP, Garg N, and Sunkar M. Vascular functions of the plasminogen activation system. Arterioscler Thromb Vasc Biol 27: 1231-1237, 2007.
14. Galan Moya EM, Le Guelte A, and Gavard J. PAKing up to the endothelium. Cell Signal 21: 1727-1737, 2009.
15. Gerthoffer WT. Mechanisms of vascular smooth muscle cell migration. Circ Res 100: 607-621, 2007.
16. Gorlach A, BelAiba RS, Hess J, and Kietzmann T. Thrombin activates the p21-activated kinase in pulmonary artery smooth muscle cells: role in tissue factor expression. Thromb Haemost 93: 1168-1175, 2005.
17. Gorlach A, Berchner-Pfannschmidt U, Wotzlaw C, Cool RH, Fandrey J, Acker H, Jungermann K, and Kietzmann T. Reactive oxygen species modulate HIF-1 mediated PAI-1 expression: involvement of the GTPase Rac1. Thromb Haemost 89: 926-935, 2003.
18. Gorlach A, Diebold I, Schini-Kerth VB, Berchner-Pfannschmidt U, Roth U, Brandes RP, Kietzmann T, and Busse R. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22 (phox)-containing NADPH oxidase. Circ Res 89: 47-54, 2001.
19. Gorlach A and Kietzmann T. Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. Methods Enzymol 435: 421-446, 2007.
20. Grobe AC, Wells SM, Benavidez E, Oishi P, Azakie A, Fi-neman JR, and Black SM. Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase. Am J Physiol Lung Cell Mol Physiol 290: L1069-L1077, 2006.
21. Herkert O, Djordjevic T, BelAiba RS, and Gorlach A. Insights into the redox control of blood coagulation: role of vascular NADPH oxidase-derived reactive oxygen species in the thrombogenic cycle. Antioxid Redox Signal 6: 765-776, 2004.
22. Hirota K and Semenza GL. Rac1 activity is required for the activation of hypoxia-inducible factor 1. J Biol Chem 276: 21166-21172, 2001.
23. Hui AS, Bauer AL, Striet JB, Schnell PO, and Czyzyk-Krzeska MF. Calcium signaling stimulates translation of HIF-alpha during hypoxia. FASEB J 20: 466-475, 2006.
24. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, and Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S-24S, 2004. (Pubitemid 38759713)
25. Kietzmann T, Roth U, and Jungermann K. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia viaa hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94: 4177-4185, 1999.
26. Kumar R, Gururaj AE, and Barnes CJ. p21-Activated kinases in cancer. Nat Rev Cancer 6: 459-471, 2006.
27. Lang IM, Moser KM, and Schleef RR. Elevated expression of urokinase-like plasminogen activator and plasminogen activator inhibitor type 1 during the vascular remodeling associated with pulmonary thromboembolism. Arterioscler Thromb Vasc Biol 18: 808-815, 1998.
28. Liu Q, Moller U, Flugel D, and Kietzmann T. Induction of plasminogen activator inhibitor I gene expression by intra-cellular calcium via hypoxia-inducible factor-1. Blood 104: 3993-4001, 2004.
29. Martyn KD, Kim MJ, Quinn MT, Dinauer MC, Knaus UG. p21-Activated kinase (Pak) regulates NADPH oxidase activation in human neutrophils. Blood 106: 3962-3969, 2005.
30. Minet E, Ernest I, Michel G, Roland I, Remacle J, Raes M, and Michiels C. HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5 UTR. Biochem Biophys Res Commun 261: 534-540, 1999.
31. Noda-Heiny H, Fujii S, and Sobel BE. Induction of vascular smooth muscle cell expression of plasminogen activator inhibitor-1 by thrombin. Circ Res 72: 36-43, 1993.
32. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, and Fineman JR. In utero placement of aorto-pulmonary shunts: a model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92: 606-613, 1995.
33. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, and Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807-811, 2008.
34. Ruas JL and Poellinger L. Hypoxia-dependent activation of HIF into a transcriptional regulator. Semin Cell Dev Biol 16: 514-522, 2005.
35. Ryan MP and Higgins PJ. Control of p52(PAI-1) gene expression in normal and transformed rat kidney cells: relationship between p52(PAI-1) induction and actin cy-toarchitecture. Adv Exp Med Biol 358: 215-230, 1994.
36. 2\+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells. Am J Physiol Lung Cell Mol Physiol 295: L1048-L1055, 2008.
37. Schofield CJ and Ratcliffe PJ. Oxygen sensing by HIF hy-droxylases. Nat Rev Mol Cell Biol 5: 343-354, 2004.
38. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 91: 803-806, 2006.
39. Stefansson S, McMahon GA, Petitclerc E, and Lawrence DA. Plasminogen activator inhibitor-1 in tumor growth, angio-genesis and vascular remodeling. Curr Pharm Des 9: 1545-1564, 2003.
40. Sugihara K, Nakatsuji N, Nakamura K, Nakao K, Hashimoto R, Otani H, Sakagami H, Kondo H, Nozawa S, Aiba A, and Katsuki M. Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 17: 3427-3433, 1998.
41. Sweeney M and Yuan JX. Hypoxic pulmonary vasocon-striction: role of voltage-gated potassium channels. Respir Res 1: 40-48, 2000.
42. Tan W, Palmby TR, Gavard J, Amornphimoltham P, Zheng Y, and Gutkind JS. An essential role for Rac1 in endothelial cell function and vascular development. FASEB J 22: 1829-1838, 2008.
43. Tang Y, Chen Z, Ambrose D, Liu J, Gibbs JB, Chernoff J, and Field J. Kinase-deficient Pak1 mutants inhibit Ras transformation of Rat-1 fibroblasts. Mol Cell Biol 17: 4454-4464, 1997.
44. Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, Yacoub M, Polak JM, and Voelkel NF. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 195: 367-374, 2001.
45. Tuder RM, Marecki JC, Richter A, Fijalkowska I, and Flores S. Pathology of pulmonary hypertension. Clin Chest Med 28: 23-42, vii, 2007.
46. Wojciak-Stothard B, Tsang LY, Paleolog E, Hall SM, and Haworth SG. Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290: L1173-L1182, 2006.
47. 2\+ and protein kinase C{delta} in vascular smooth muscle cells. Am J Physiol Cell Physiol 289: C1286-C1294, 2005.
48. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, and Semenza GL. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 103: 691-696, 1999.